Corcept Therapeutics | CORT - Ebit


Corcept Therapeutics reported $4.49M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Acadia Pharmaceuticals USD 17.39M 18.36M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Ardelyx USD 5.1M 2.02M Dec/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Lexicon Pharmaceuticals USD -14.78M 2.59M Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novartis USD 4.06B 530M Dec/2025
Novartis USD 4.06B 413M Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
Pacira USD 3.19M 9.96M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
TG Therapeutics USD 50.49M 21.13M Dec/2025